D-1388-2020 Class III Terminated

Recalled by Akorn, Inc. — Lake Forest, IL

FDA drug recall D-1388-2020 was initiated by Akorn, Inc. on Dec 26, 2019 and is designated Class III. Reason for recall: Chemical contamination; out of specification results obtained for equipment cleaning residue rinse sample The recall status is terminated (terminated Jul 28, 2022). Affected quantity: 33,343 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 22, 2020
Initiation Date
Dec 26, 2019
Termination Date
Jul 28, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
33,343 bottles

Product description

Proparacaine Hydrochloride Ophthalmic Solution, USP, 0.5%, 15 mL per dropper bottle, Sterile, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-263-12

Reason for recall

Chemical contamination; out of specification results obtained for equipment cleaning residue rinse sample

Distribution pattern

Nationwide USA and Puerto Rico

Code information

Lot 9E52A, exp 04/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1388-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1388-2020. Report a data issue: hello@regdatalab.com.